CellTran Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 12
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $288K
Latest Deal Amount

CellTran General Information

Description

Developer of cell therapy products for treatment of burns and ulcers. The company develops treatment for chronic, complex or non-healing wounds using advanced polymer surface technology and the autologous and allogeneic cells cultured from the patients living cells, providing patients suffering from chronic burns with skin transplants that avoids hostile reactions from the body.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
York Pharma
Primary Office
  • The Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CellTran Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 28-Oct-2008 $288K 00000 Completed Bankruptcy: Admin/Reorg
6. Bankruptcy: Admin/Reorg 16-Jun-2008 Completed Bankruptcy: Admin/Reorg
5. Later Stage VC 24-Aug-2007 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 04-Aug-2005 00.000 00.000 Completed Product Development
3. Early Stage VC 01-Feb-2005 00000 00.00 Completed Product Development
2. Early Stage VC 01-Jan-2004 $1.05M $1.43M Completed Product Development
1. Seed Round 01-Aug-2000 $377K $377K Completed Startup
To view CellTran’s complete valuation and funding history, request access »

CellTran Executive Team (2)

Name Title Board Seat Contact Info
Sheila MacNeil Co-Founder & Research and Development Director
You’re viewing 1 of 2 executive team members. Get the full list »

CellTran Board Members (1)

Name Representing Role Since
Robert Short CellTran Co-Founder & Nominal Chairman 000 0000
To view CellTran’s complete board members history, request access »

CellTran Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellTran Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Finance Yorkshire Venture Capital Minority 000 0000 000000 0
FusionIP Venture Capital Minority 000 0000 000000 0
Innogenetics Corporation Minority 000 0000 000000 0
PUK Ventures Fund of Funds Minority 000 0000 000000 0
Wellcome Trust Limited Partner Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

CellTran Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 02-Oct-2006 000000000000000000 Biotechnology 000000 00000
To view CellTran’s complete acquisitions history, request access »